ADAPTABLE Study
Share
ADAPTABLE (Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness) is comparing two daily doses of aspirin widely used to prevent heart attacks and strokes in individuals living with heart disease. What we learn from the ADAPTABLE study will improve care and outcomes for patients with heart disease and could prevent as many as 88,800 deaths per year around the wor
12/07/2018
Today we reached 12 thousand participants enrolled! Congratulations to the team on your continued success in transforming & understanding what is the best dose of aspirin for people with .
03/22/2018
Interested in learning more about patient-researcher partnerships? The ADAPTABLE Study team shares their experiences at the CardioSmart Patient Engagement Pavilion, ACC 18
ADAPTABLE Study Team Shares Patient Engagement Experiences in CardioSmart Pavilion at American College Cardiology Conference - Adaptable Jacqueline Alikhaani, a rare disease heart patient and partner on the ADAPTABLE Study, is passionate about the value and impact of novel clinical research studies. Alikhaani is especially passionate about studies that leverage electronic health records and common data resources, and includes patient...
Click here to claim your Sponsored Listing.
Contact the school
Website
Address
32801–32899
